Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions

NCT02306889 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ranbaxy Laboratories Limited